Maryam Pashaiasl

Dr. Maryam Pashaiasl

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2019 in Cell and Tissue Banking
Verified
Journal Article
Closed access
PDF file
MEMaryam Ezzati
Maryam Ezzati
DSDariush Shanehbandi
Dariush Shanehbandi
KHKobra Hamdi
Kobra Hamdi
SRSara Rahbar
Sara Rahbar
MPMaryam Pashaiasl
Maryam Pashaiasl

19 March 2012 in Stem Cells International
Verified
Journal Article
Open access
PDF file
KKKhodadad Khodadadi
Khodadad Khodadadi
Huseyin SumerHuseyin Sumer
Huseyin Sumer
MPMaryam Pashaiasl
Maryam Pashaiasl
SLSusan Lim
Susan Lim
MWMark Williamson
Mark Williamson
PVPaul J. Verma
Paul J. Verma
Despite tremendous efforts on isolation of pluripotent equine embryonic stem (ES) cells, to date there are few reports about successful isolation of ESCs and no report ofin vivodifferentiation of this important companion species. We report the induction of pluripotency in adult equine fibroblasts via retroviral transduction with three transcription factors usingOCT4, SOX2, andKLF4in the absence of c-MYC. The cell lines were maintained beyond 27 passages (more than 11 months) and characterized. The equine iPS (EiPS) cells stained positive for alkaline phosphatase by histochemical staining and expressed OCT4, NANOG, SSEA1, and SSEA4. Gene expression analysis of the cells showed the expression ofOCT4, SOX2 NANOG, andSTAT3. The cell lines retained a euploid chromosome count of 64 after long-term culture cryopreservation. The EiPS demonstrated differentiation capacity for the three embryonic germ layers bothin vitroby embryoid bodies (EBs) formation andin vivoby teratoma formation. In conclusion, we report the derivation of iPS cells from equine adult fibroblasts and long-term maintenance using either of the three reprogramming factors.

30 November 2015 in International Journal of Stem Cells
Verified
Journal Article
Open access
PDF file
SAShiva Gholizadeh-Ghaleh Aziz
Shiva Gholizadeh-Ghaleh Aziz
RFRaheleh Farahzadi
Raheleh Farahzadi
EFEzzatollah Fathi
Ezzatollah Fathi
MPMaryam Pashaiasl
Maryam Pashaiasl
Shiva Gholizadeh-Ghalehaziz, Raheleh Farahzadi, Ezzatollah Fathi, and Maryam Pashaiasl. International Journal of Stem Cells 2015;8:115-20. http://dx.doi.org/10.15283/ijsc.2015.8.2.115

30 June 2017 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
RPRoghiyeh Pashaei-Asl
Roghiyeh Pashaei-Asl
FPFatima Pashaei-Asl
Fatima Pashaei-Asl
PGParvin Mostafa Gharabaghi
Parvin Mostafa Gharabaghi
KKKhodadad Khodadadi
Khodadad Khodadadi
MEMansour Ebrahimi
Mansour Ebrahimi
MPMaryam Pashaiasl
Maryam Pashaiasl
The Inhibitory Effect of Ginger Extract on Ovarian Cancer Cell Line; Application of Systems Biology

10 August 2016 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Closed access
SAShiva Gholizadeh-Ghaleh Aziz
Shiva Gholizadeh-Ghaleh Aziz
EFEzzatollah Fathi
Ezzatollah Fathi
MRMohammad Rahmati-Yamchi
Mohammad Rahmati-Yamchi
AAAbolfazl Akbarzadeh
Abolfazl Akbarzadeh
ZFZahra Fardyazar
Zahra Fardyazar
MPMaryam Pashaiasl
Maryam Pashaiasl
Recent studies have elucidated that cell-based therapies are promising for cancer treatments. The human amniotic fluid stem (AFS) cells are advantageous cells for such therapeutic schemes that can be innately changed to express therapeutic proteins. HAFSCs display a natural tropism to cancer cells in vivo. They can be useful in cancer cells targeting. Moreover, they are easily available from surplus diagnostic samples during pregnancy and less ethical and legal concern are associated with the collection and application than other putative cells are subjected. This review will designate representatives of amniotic fluid and stem cell derived from amniotic fluid. For this propose, we collect state of human AFS cells data applicable in cancer therapy by dividing this approach into two main classes (nonengineered and engineered based approaches). Our study shows the advantage of AFS cells over other putative cells types in terms differentiation ability to a wide range of cells by potential and effective use in preclinical studies for a variety of diseases. This study has shown the elasticity of human AFS cells and their favorable potential as a multipotent cell source for regenerative stem cell therapy and capable of giving rise to multiple lineages including such as osteoblasts and adipocyte.

18 April 2017 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
ZSZahra Shakoori
Zahra Shakoori
HGHossein Ghanbari
Hossein Ghanbari
YOYadollah Omidi
Yadollah Omidi
MPMaryam Pashaiasl
Maryam Pashaiasl
AAAbolfazl Akbarzadeh
Abolfazl Akbarzadeh
SDSoodabeh Davaran
Soodabeh Davaran
Magnetic, pH and temperature-sensitive, poly(N-isopropylacrylamide) (PNIPAM)-based nanocomposites with fluorescent properties were synthesized by free radical copolymerization-cross linking of NIPAM, N,N-dimethylaminoethyl methacrylate (DMAEMA) and 4-acrylamidofluorescein (AFA). The model anti-cancer drug, cisplatin (CDDP), was loaded into the resulted nanogel. For the production of CDDP-loaded nanocomposite, Fe3O4 magnetic nanoparticles (MNPs) and CDDP were loaded into the nanogel. Field-emission scanning electron microscopy (FE-SEM) indicated that the size of nanogel and CDDP-loaded nanocomposite were about 90 and 160 nm, respectively. The encapsulation efficiency of CCDP was found up to 65%. The loaded CCDP showed sustained thermal and pH-responsive drug release. A high level of drug release was observed under the conditions of low pH and high temperature. The lower critical solution temperature (LCST) of synthesized nanogel was about 40 °C. CDDP-loaded nanocomposite showed a volume phase transition from 282 to 128 nm at its LCST. Accordingly, in this study, the synthesized nanocomposite can be employed as a stimuli-responsive anti-cancer drug delivery system and the pH and temperature of solution have the potential to monitor the drug release.